Mammography controversy needs greater participation to inform decisions

May 5, 2014, International Menopause Society

Doctors at the World Congress on the Menopause in Cancun, Mexico, have called for any decision to participate in mammography to be a based on an informed choice and consideration of all factors, rather than just be an automatic process.

A major session at the World Congress on the Menopause has debated the benefits and risks associated with regular mammography. The potential benefit of mammography is earlier detection of , but increasing evidence has shown that mammography also uncovers some cancers which would not go onto cause any problem, and many believe that this overdiagnosis can cause real harm through unnecessary treatment . The debate in the scientific press has led to confusion in the minds of many , who hope for a definitive answer on whether or not they should undergo regular mammography.

Now two prominent doctors from opposing sides of the debate have agreed that women need to be more involved in making decisions on whether or not mammography is right for them.

Dr Eugenio Paci presented work from the EUROSCREEN working group, showing that overdiagnosis is at the lower end of the estimates, indicating that mammography saves lives. This work indicates that screening 1000 women saves up to 7 lives, with only 4 overdiagnosis. Professor Robin Bell presented an analysis showing that up to 40% of invasive breast cancer cases identified in women invited for mammography may be overdiagnosed, and says that the total number of deaths in screened patients does not drop when measured against non-screened patients, indicating that screening has few benefits.

However, both doctors called for changes in the way mammography is dealt with.

Eugeni Paci (Florence, Italy) said, "There has been a lot of press interest in the pros and cons of mammography, and women need to be able to make sense of this. Our analysis shows that mammography saves lives, but we know that a certain amount of overdiagnosis exists: this is effectively a potential medical harm. Women need to be able to discuss the use of mammography and any treatment, to allow them to make decisions which are right for them, and we would urge healthcare providers and doctors to allow women to take more involvement in these important choices: they need to be more involved in the decision making process, so that if they do go ahead with regular mammography then they can feel comfortable about their decision. We also need a better understanding of just how aggressive- or not - a cancer might be, so more research on this is urgently needed.

The problem is not really with the screening, it's what you do when it looks like you have found something suspicious. But I believe that screening needs to continue and to be improved."

Professor Robin Bell (Melbourne, Australia) said, "I think that it is time for a review of the routine invitation of women for screening mammography. When women receive an invitation for screening mammography they reasonably assume that on balance the benefits for them outweigh the risks. If there was no routine invitation for screening, then the onus would be on the woman to pursue screening and she could discuss in detail the pros and cons of screening with her health care provider. This would encourage the presentation of balanced information about the benefits and harms of and ensure women give truly informed consent for the procedure."

In a joint statement, both doctors joined in saying that "Women and doctors need to move to a new, more inclusive way of communicating the risks and benefit of mammography."

Commenting for the International Menopause Society, Professor Susan Davis (Melbourne, Australia) said, "Women need to be aware that almost nothing in medicine is either completely good or completely bad –treatments which benefit will have potential side effects. The variables are complex, and we are unlikely to get definitive data which says yes or no to , so we need to make decisions based on what we have. These are not just physical health issues, the possibility of contracting breast cancer is highly emotive for many women – it's the disease women fear the most, even if it's not the biggest killer. This shows that there are limits to what can be achieved by relying only on evidence based medicine. Doctors need to take time to explain the evidence to women, but also what this means, so that women can make an ."

Explore further: Experts question routine mammograms in elderly

Related Stories

Experts question routine mammograms in elderly

April 1, 2014
Doctors should focus on life expectancy when deciding whether to order mammograms for their oldest female patients, since the harms of screening likely outweigh the benefits unless women are expected to live at least another ...

Review quantifies benefits, harms of mammography

January 5, 2014
(HealthDay)—The benefits and harms of screening mammography have been quantified in a special communication published online Dec. 30 in JAMA Internal Medicine.

The mammography dilemma: Complex benefits and harms of mammography require individualized approach

April 1, 2014
A comprehensive review of 50 year's worth of international studies assessing the benefits and harms of mammography screening suggests that the benefits of the screening are often overestimated, while harms are underestimated. ...

Annual screening does not cut breast cancer deaths, Canadian study suggests

February 11, 2014
Annual screening in women aged 40-59 does not reduce mortality from breast cancer beyond that of physical examination or usual care, concludes a 25-year study from Canada published in BMJ today.

Benefit of breast cancer screening more consistent across studies than previously understood

December 11, 2013
Re-examination of data from four large studies of the benefits and harms of mammography screening shows that the benefits are more consistent across these studies than previously understood and that all the studies indicate ...

Many women shocked about breast screening overdiagnosis but would still go for a mammography

April 24, 2013
Women are surprised and shocked that breast screening can lead to 'overdiagnosis' of cancer, but would rather go for screening than take the risk of missing a cancer that could be treated, according to new research published ...

Recommended for you

New approach attacks 'undruggable' cancers from the outside in

January 23, 2018
Cancer researchers have made great strides in developing targeted therapies that treat the specific genetic mutations underlying a patient's cancer. However, many of the most common cancer-causing genes are so central to ...

Study: Cells of three advanced cancers die with drug-like compounds that reverse chemo failure

January 23, 2018
Researchers at Southern Methodist University have discovered three drug-like compounds that successfully reverse chemotherapy failure in three of the most commonly aggressive cancers—ovarian, prostate and breast.

'Hijacker' drives cancer in some patients with high-risk neuroblastoma

January 23, 2018
Researchers have identified mechanisms that drive about 10 percent of high-risk neuroblastoma cases and have used a new approach to show how the cancer genome "hijacks" DNA that regulates other genes. The resulting insights ...

Enzyme inhibitor combined with chemotherapy delays glioblastoma growth

January 23, 2018
In animal experiments, a human-derived glioblastoma significantly regressed when treated with the combination of an experimental enzyme inhibitor and the standard glioblastoma chemotherapy drug, temozolomide.

Researchers identify a protein that keeps metastatic breast cancer cells dormant

January 23, 2018
A study headed by ICREA researcher Roger Gomis at the Institute for Research in Biomedicine (IRB Barcelona) has identified the genes involved in the latent asymptomatic state of breast cancer metastases. The work sheds light ...

Boosting cancer therapy with cross-dressed immune cells

January 22, 2018
Researchers at EPFL have created artificial molecules that can help the immune system to recognize and attack cancer tumors. The study is published in Nature Methods.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.